Boston, MA, United States of America

Robert Alexander Wesselhoeft

This inventor holds 18 USPTO granted patents and 10 published patent applications, primarily in RNA Therapeutics. Top assignees: Orna Therapeutics, Inc., Massachusetts Institute of Technology. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Alexander Wesselhoeft. Retrieved from https://idiyas.com/inventor/robert-alexander-wesselhoeft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 51(Granted Patents)


Location History:

  • Boston, MA (US) (2021 - 2024)
  • Cambridge, MA (US) (2023 - 2024)

Company Filing History:


Years Active: 2021-2026

Loading Chart...
Areas of Expertise:
Circular RNA
Eukaryotic Cells
Lipid Nanoparticles
Polynucleotides
RNA Compositions
Translation
Gene Delivery
Therapeutics
18 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Robert Alexander Wesselhoeft

Introduction

Robert Alexander Wesselhoeft is a distinguished inventor based in Boston, Massachusetts. With a remarkable portfolio of 13 patents, Wesselhoeft has significantly contributed to the field of biotechnology, particularly in the realm of therapeutic delivery systems.

Latest Patents

Among his notable innovations, his recent patents focus on "Lipid nanoparticle compositions for delivering circular polynucleotides." These patents disclose novel lipids that can be used alongside other lipid components such as helper lipids, structural lipids, and cholesterols. The goal of these compositions is to form lipid nanoparticles capable of delivering therapeutic agents, including nucleic acids, both in vitro and in vivo. This innovative approach holds promise for enhancing the efficacy of various treatments.

Career Highlights

Wesselhoeft has worked with esteemed institutions such as the Massachusetts Institute of Technology (MIT) and Orna Therapeutics, Inc. His work at these organizations has enabled him to pioneer advancements in the delivery of nucleic acid therapies, contributing to the ongoing evolution of biotechnology and medicine.

Collaborations

In his professional journey, Wesselhoeft has collaborated with notable colleagues, including Daniel Griffith Anderson and Allen T. Horhota. These partnerships reflect his commitment to fostering innovation through teamwork and shared expertise in the scientific community.

Conclusion

Robert Alexander Wesselhoeft stands out as a visionary inventor whose work continues to shape the landscape of therapeutic delivery systems. His contributions not only enhance current medical practices but also pave the way for future innovations in the field. As biotechnology advances, Wesselhoeft's legacy will undoubtedly inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…